Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Bladder Cancer

  Free Subscription


17.08.2020

1 Am J Cancer Res
1 Am J Clin Nutr
1 Anesth Analg
1 Anticancer Agents Med Chem
1 Anticancer Res
4 Beijing Da Xue Xue Bao Yi Xue Ban
1 Biomolecules
1 Biosci Rep
3 BJU Int
1 Bladder (San Franc)
2 Bladder Cancer
1 CA Cancer J Clin
2 Cancer Med
1 Cancer Sci
1 Cell Death Discov
2 Cells
1 Cent European J Urol
1 Clin Genitourin Cancer
1 Clin Oncol (R Coll Radiol)
1 Curr Urol
2 Eur Urol
1 Eur Urol Focus
1 Exp Ther Med
1 Expert Opin Drug Deliv
1 Int Immunopharmacol
2 Int J Biol Sci
1 Int J Clin Exp Pathol
2 Int J Mol Sci
1 Int J Urol
1 J Magn Reson Imaging
1 J Urol
1 Kaohsiung J Med Sci
1 Lancet Haematol
1 Medicine (Baltimore)
1 Minerva Chir
1 Mol Biol Rep
1 Mol Cancer
1 Mol Cell Biochem
1 Mutagenesis
1 Onco Targets Ther
3 Oncol Lett
1 Proc Jpn Acad Ser B Phys Biol Sci
1 Radiother Oncol
1 Scand J Urol
1 Sci Rep
1 Ther Adv Urol
2 Urol Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Cancer Res

  1. CHANG HC, Lin CT, Lin WY, Yu PT, et al
    Analysis of the effects of cyproheptadine on bladder cancer through big data.
    Am J Cancer Res. 2020;10:2114-2119.
    PubMed         Abstract available


    Am J Clin Nutr

  2. YU EYW, Wesselius A, Mehrkanoon S, Brinkman M, et al
    Grain and dietary fiber intake and bladder cancer risk: a pooled analysis of prospective cohort studies.
    Am J Clin Nutr. 2020 Aug 10. pii: 5890707. doi: 10.1093.
    PubMed         Abstract available


    Anesth Analg

  3. KIM DH, Park JY, Yu J, Lee SA, et al
    Intravenous Lidocaine for the Prevention of Postoperative Catheter-Related Bladder Discomfort in Male Patients Undergoing Transurethral Resection of Bladder Tumors: A Randomized, Double-Blind, Controlled Trial.
    Anesth Analg. 2020;131:220-227.
    PubMed         Abstract available


    Anticancer Agents Med Chem

  4. POURHANIFEH MH, Mottaghi R, Razavi ZS, Shafiee A, et al
    Therapeutic Applications of Curcumin and its Novel Formulations in the Treatment of Bladder Cancer: A Review of Current Evidence.
    Anticancer Agents Med Chem. 2020 Aug 7. pii: ACAMC-EPUB-108970.
    PubMed         Abstract available


    Anticancer Res

  5. TAKEMOTO K, Teishima J, Kohada Y, Ikeda K, et al
    The Impact of Histological Variant on Oncological Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy.
    Anticancer Res. 2020;40:4787-4793.
    PubMed         Abstract available


    Beijing Da Xue Xue Bao Yi Xue Ban

  6. WANG T, Hong X, Wang XF
    [Clinical application of the needle electrode in transurethral plasmakinetic resection of bladder tumor around ureteral orifice: A report of 16 cases].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2020;52:632-636.
    PubMed         Abstract available

  7. WANG H, Jiang SK, Peng R, Huang Y, et al
    [Individual control of urine volume to improve stability of bladder volume in radiotherapy of urinary tumor].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2020;52:688-691.
    PubMed         Abstract available

  8. QIU M, Xu CX, Wang BS, Yan Y, et al
    [Analysis of self-control trial results of narrow band imaging and white light in transurethral resection of bladder tumor].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2020;52:697-700.
    PubMed         Abstract available

  9. ZHAO SM, Yang TJ, Xu CM, Guo XF, et al
    [Bladder cancer local staging about muscle invasion: 3.0T MRI performance following transurethral resection].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2020;52:701-704.
    PubMed         Abstract available


    Biomolecules

  10. ASHRAFIZADEH M, Hushmandi K, Hashemi M, Akbari ME, et al
    Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer.
    Biomolecules. 2020;10.
    PubMed         Abstract available


    Biosci Rep


  11. Correction: Cisplatin contributes to programmed death-ligand 1 expression in bladder cancer through ERK1/2-AP-1 signaling pathway.
    Biosci Rep. 2020;40.
    PubMed        


    BJU Int

  12. LEE SH, Mahendran R, Tham SM, Thamboo TP, et al
    Combination Bacillus Calmette-Guerin and indoleamine 2,3-dioxygenase 1 inhibitor therapy of murine orthotopic bladder cancer.
    BJU Int. 2020 Aug 8. doi: 10.1111/bju.15201.
    PubMed         Abstract available

  13. GALLAGHER KM, Bhatt NR, Clement K, Kulkarni M, et al
    Study launch: transurethral REsection and Single instillation intra-vesical chemotherapy Evaluation in bladder Cancer Treatment (RESECT).
    BJU Int. 2020;126:310-311.
    PubMed        

  14. LEE SH, Mahendran R, Tham SM, Thamboo TP, et al
    Tryptophan/kynurenine ratio as biomarker of bladder cancer.
    BJU Int. 2020 Aug 13. doi: 10.1111/bju.15205.
    PubMed         Abstract available


    Bladder (San Franc)

  15. CHANG DTS, Picardo A
    Repeat transurethral resection is still an essential tool in treating non-muscle invasive bladder cancer: the Western Australian experience.
    Bladder (San Franc). 2020;7:e42.
    PubMed         Abstract available


    Bladder Cancer

  16. BOXLEY P, Plets M, Flaig TW
    Review of SWOG S1314: Lessons from a Randomized Phase II Study of Co-Expression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer.
    Bladder Cancer. 2020;6:123-129.
    PubMed         Abstract available

  17. YANG A, Cross CN, Townsend JP
    Non-Coding Mutations in Urothelial Bladder Cancer: Biological and Clinical Relevance and Potential Utility as Biomarkers.
    Bladder Cancer. 2020;6:211-213.
    PubMed        


    CA Cancer J Clin

  18. PATEL VG, Oh WK, Galsky MD
    Treatment of muscle-invasive and advanced bladder cancer in 2020.
    CA Cancer J Clin. 2020 Aug 7. doi: 10.3322/caac.21631.
    PubMed         Abstract available


    Cancer Med

  19. LI P, Cao J, Li J, Yao Z, et al
    Identification of prognostic biomarkers associated with stromal cell infiltration in muscle-invasive bladder cancer by bioinformatics analyses.
    Cancer Med. 2020 Aug 12. doi: 10.1002/cam4.3372.
    PubMed         Abstract available

  20. AOE J, Ito Y, Fukui K, Nakayama M, et al
    Long-term trends in sex difference in bladder cancer survival 1975-2009: A population-based study in Osaka, Japan.
    Cancer Med. 2020 Aug 13. doi: 10.1002/cam4.3382.
    PubMed         Abstract available


    Cancer Sci

  21. WANG L, Zhang Q, Wu P, Xiang W, et al
    SLC12A5 interacts and enhances SOX18 activity to promote bladder urothelial carcinoma progression via upregulating MMP7.
    Cancer Sci. 2020;111:2349-2360.
    PubMed         Abstract available


    Cell Death Discov

  22. CLAUSEN TM, Kumar G, Ibsen EK, Orum-Madsen MS, et al
    A simple method for detecting oncofetal chondroitin sulfate glycosaminoglycans in bladder cancer urine.
    Cell Death Discov. 2020;6:65.
    PubMed         Abstract available


    Cells

  23. ILIJAZI D, Pulverer W, Ertl IE, Lemberger U, et al
    Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder Cancer.
    Cells. 2020;9.
    PubMed         Abstract available

  24. NUNES SP, Henrique R, Jeronimo C, Paramio JM, et al
    DNA Methylation as a Therapeutic Target for Bladder Cancer.
    Cells. 2020;9.
    PubMed         Abstract available


    Cent European J Urol

  25. MIELCZAREK L, Zapala P, Krajewski W, Nowak L, et al
    Diagnostic and treatment delays among patients with primary bladder cancer in Poland: a survey study.
    Cent European J Urol. 2020;73:152-159.
    PubMed         Abstract available


    Clin Genitourin Cancer

  26. DEUKER M, Martin T, Stolzenbach F, Rosiello G, et al
    Bladder Cancer: A Comparison Between Non-urothelial Variant Histology and Urothelial Carcinoma Across All Stages and Treatment Modalities.
    Clin Genitourin Cancer. 2020 Jul 18. pii: S1558-7673(20)30171.
    PubMed         Abstract available


    Clin Oncol (R Coll Radiol)

  27. HAFEEZ S, Lewis R, Griffin C, Hall E, et al
    Failing to Close the Gap Between Evidence and Clinical Practice in Radical Bladder Cancer Radiotherapy.
    Clin Oncol (R Coll Radiol). 2020 Aug 3. pii: S0936-6555(20)30283.
    PubMed        


    Curr Urol

  28. WAN JCM
    Survival Outcomes of Early versus Deferred Cystectomy for High-Grade Non-Muscle-Invasive Bladder Cancer: A Systematic Review.
    Curr Urol. 2020;14:66-73.
    PubMed         Abstract available


    Eur Urol

  29. WARD DG, Arnold R, Bryan RT
    Molecular Subtypes of T1 Bladder Cancer: Biomolecular Characteristics Versus Clinical Utility.
    Eur Urol. 2020 Aug 6. pii: S0302-2838(20)30569.
    PubMed        

  30. MOSTAFID H
    Neoadjuvant Intravesical Therapy for Non-muscle-invasive Bladder Cancer: A New Approach for Old Agents?
    Eur Urol. 2020 Aug 9. pii: S0302-2838(20)30598.
    PubMed        


    Eur Urol Focus

  31. MIR MC, Marchioni M, Zargar H, Zargar-Shoshtari K, et al
    Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium.
    Eur Urol Focus. 2020 Aug 5. pii: S2405-4569(20)30208.
    PubMed         Abstract available


    Exp Ther Med

  32. HUANG Z, Wang T, Xia W, Li Q, et al
    Oblongifolin C reverses GEM resistance via suppressing autophagy flux in bladder cancer cells.
    Exp Ther Med. 2020;20:1431-1440.
    PubMed         Abstract available


    Expert Opin Drug Deliv

  33. CHOI YW, Yoon HY, Yang HM, Kim CH, et al
    Current status of the development of intravesical drug delivery systems for the treatment of bladder cancer.
    Expert Opin Drug Deliv. 2020 Aug 13. doi: 10.1080/17425247.2020.1810016.
    PubMed         Abstract available


    Int Immunopharmacol

  34. TANG Y, Hu Y, Wang J, Zeng Z, et al
    A novel risk score based on a combined signature of 10 immune system genes to predict bladder cancer prognosis.
    Int Immunopharmacol. 2020;87:106851.
    PubMed         Abstract available


    Int J Biol Sci

  35. SHAHID M, Kim M, Jin P, Zhou B, et al
    S-Palmitoylation as a Functional Regulator of Proteins Associated with Cisplatin Resistance in Bladder Cancer.
    Int J Biol Sci. 2020;16:2490-2505.
    PubMed         Abstract available

  36. CHEN YT, Huang CR, Chang CL, Chiang JY, et al
    Jagged2 progressively increased expression from Stage I to III of Bladder Cancer and Melatonin-mediated downregulation of Notch/Jagged2 suppresses the Bladder Tumorigenesis via inhibiting PI3K/AKT/mTOR/MMPs signaling.
    Int J Biol Sci. 2020;16:2648-2662.
    PubMed         Abstract available


    Int J Clin Exp Pathol

  37. CHEN Z, Zhang F, Zhang S, Ma L, et al
    The down-regulation of SNCG inhibits the proliferation and invasiveness of human bladder cancer cell line 5637 and suppresses the expression of MMP-2/9.
    Int J Clin Exp Pathol. 2020;13:1873-1879.
    PubMed         Abstract available


    Int J Mol Sci

  38. LEE KH, Kim BC, Jeong SH, Jeong CW, et al
    Histone Demethylase KDM7A Regulates Androgen Receptor Activity, and Its Chemical Inhibitor TC-E 5002 Overcomes Cisplatin-Resistance in Bladder Cancer Cells.
    Int J Mol Sci. 2020;21.
    PubMed         Abstract available

  39. MINOLI M, Kiener M, Thalmann GN, Kruithof-de Julio M, et al
    Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications.
    Int J Mol Sci. 2020;21.
    PubMed         Abstract available


    Int J Urol

  40. IWASAWA T, Niwa N, Matsumoto K, Komatsuda A, et al
    Reduced recurrence of low-risk non-muscle-invasive bladder cancer is associated with low urine-specific gravity.
    Int J Urol. 2020 Aug 13. doi: 10.1111/iju.14351.
    PubMed         Abstract available


    J Magn Reson Imaging

  41. XU X, Zhang X, Tian Q, Wang H, et al
    Quantitative Identification of Nonmuscle-Invasive and Muscle-Invasive Bladder Carcinomas: A Multiparametric MRI Radiomics Analysis.
    J Magn Reson Imaging. 2018 Sep 25. doi: 10.1002/jmri.26327.
    PubMed         Abstract available


    J Urol

  42. HAJIRAN A, Azizi M, Aydin AM, Zemp L, et al
    Pathologic and Survival Outcomes Associated with Variant Histology Bladder Cancers Managed with Cystectomy with or Without Neoadjuvant Chemotherapy.
    J Urol. 2020 Aug 12:101097JU0000000000001325. doi: 10.1097/JU.0000000000001325.
    PubMed         Abstract available


    Kaohsiung J Med Sci

  43. GAO ZY, Yu F, Jia HX, Ye Z, et al
    ASPM predicts poor prognosis and regulates cell proliferation in bladder cancer.
    Kaohsiung J Med Sci. 2020 Aug 6. doi: 10.1002/kjm2.12284.
    PubMed         Abstract available


    Lancet Haematol

  44. COOKSON E
    2020 ASCO Annual Meeting.
    Lancet Haematol. 2020;7:e507.
    PubMed        


    Medicine (Baltimore)

  45. ZHANG L, Li L, Liu J, Wang J, et al
    Meta-analysis of multiple hematological biomarkers as prognostic predictors of survival in bladder cancer.
    Medicine (Baltimore). 2020;99:e20920.
    PubMed         Abstract available


    Minerva Chir

  46. PANARELLO D, Quaglia M, Mantica G, Cantaluppi V, et al
    Bladder cancer following renal transplantation: experiences with radical cystectomy and adjuvant radiotherapy.
    Minerva Chir. 2020 Aug 6. pii: S0026-4733.20.08377.
    PubMed        


    Mol Biol Rep

  47. GHASEMI H, Amini MA, Pegah A, Azizi E, et al
    Overexpression of reactive oxygen species modulator 1 is associated with advanced grades of bladder cancer.
    Mol Biol Rep. 2020 Aug 8. pii: 10.1007/s11033-020-05702.
    PubMed         Abstract available


    Mol Cancer

  48. LIU H, Bi J, Dong W, Yang M, et al
    Correction to: Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis.
    Mol Cancer. 2020;19:124.
    PubMed         Abstract available


    Mol Cell Biochem

  49. JIANG P, Zhu Y, Xu Z, Chen X, et al
    Interference with circBC048201 inhibits the proliferation, migration, and invasion of bladder cancer cells through the miR-1184/ITGA3 axis.
    Mol Cell Biochem. 2020 Aug 12. pii: 10.1007/s11010-020-03835.
    PubMed         Abstract available


    Mutagenesis

  50. LIMA APB, Almeida TC, Barros TMB, Rocha LCM, et al
    Toxicogenetic and antiproliferative effects of chrysin in urinary bladder cancer cells.
    Mutagenesis. 2020 Aug 13. pii: 5892015. doi: 10.1093.
    PubMed         Abstract available


    Onco Targets Ther

  51. LV SW, Shi ZG, Wang XH, Zheng PY, et al
    Ribosome Binding Protein 1 Correlates with Prognosis and Cell Proliferation in Bladder Cancer.
    Onco Targets Ther. 2020;13:6699-6707.
    PubMed         Abstract available


    Oncol Lett

  52. WANG LA, Yang B, Tang T, Yang Y, et al
    Correlation of APE1 with VEGFA and CD163(+) macrophage infiltration in bladder cancer and their prognostic significance.
    Oncol Lett. 2020;20:2881-2887.
    PubMed         Abstract available

  53. NIU W, Xu L, Li J, Zhai Y, et al
    Polyphyllin II inhibits human bladder cancer migration and invasion by regulating EMT-associated factors and MMPs.
    Oncol Lett. 2020;20:2928-2936.
    PubMed         Abstract available

  54. SUN D, Li T, Xin H, An J, et al
    miR-489-3p inhibits proliferation and migration of bladder cancer cells through downregulation of histone deacetylase 2.
    Oncol Lett. 2020;20:8.
    PubMed         Abstract available


    Proc Jpn Acad Ser B Phys Biol Sci

  55. KAKIZOE T
    Orthotopic neobladder after cystectomy for bladder cancer.
    Proc Jpn Acad Ser B Phys Biol Sci. 2020;96:255-265.
    PubMed         Abstract available


    Radiother Oncol

  56. VOSKUILEN CS, van de Kamp MW, Schuring N, Mertens LS, et al
    Radiation with concurrent radiosensitizing capecitabine tablets and single-dose mitomycin-C for muscle-invasive bladder cancer: a convenient alternative to 5-fluorouracil.
    Radiother Oncol. 2020 Aug 5. pii: S0167-8140(20)30716.
    PubMed         Abstract available


    Scand J Urol

  57. BLINDHEIM A, Fossa S, Babigumira R, Myklebust TA, et al
    T1 bladder cancer in Norway: treatment and survival.
    Scand J Urol. 2020 Aug 12:1-6. doi: 10.1080/21681805.2020.1803401.
    PubMed         Abstract available


    Sci Rep

  58. SEYAM RM, Zeitouni OM, Alsibai TM, AlAyoub AJ, et al
    The grasper-integrated disposable flexible cystoscope is comparable to the reusable, flexible cystoscope for the detection of bladder cancer.
    Sci Rep. 2020;10:13495.
    PubMed         Abstract available


    Ther Adv Urol

  59. CHENG TC, Lee YH, Chang YP, Lee DC, et al
    Improved urinary melatonin level as the perspective indicator that leads to better sleeping quality in bladder cancer patients.
    Ther Adv Urol. 2020;12:1756287220940870.
    PubMed         Abstract available


    Urol Oncol

  60. ONISHI T, Sekito S, Shibahara T, Yabana T, et al
    Impact of noninvasive down-staging after transurethral resection of bladder tumor plus systemic chemotherapy on bladder-sparing strategy in patients with muscle-invasive bladder cancer.
    Urol Oncol. 2020 Aug 10. pii: S1078-1439(20)30337.
    PubMed         Abstract available

  61. MAAS M, Mayer L, Hennenlotter J, Stuhler V, et al
    Prognostic impact of somatostatin receptor expression in advanced bladder cancer.
    Urol Oncol. 2020 Aug 7. pii: S1078-1439(20)30327.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: